Medway School of Pharmacy, University of Kent

3 year full time  PhD project

 Chatham Maritime, Kent, UK

 Self-funded Students

 £15,380 + bench fees

 Full Time

Closing date: 31st March 2016

PhD Start Date: October 2016.

Supervisor: Dr Nigel Temperton, n.temperton@kent.ac.uk (http://orcid.org/0000-0002-7978-3815)

The Project:

A 3-year full-time PhD project is offered in the laboratory of Dr Nigel Temperton within the Medway School of Pharmacy Viral Pseudotype Unit (VPU), University of Kent (http://www.msp.ac.uk/about/staff/biological/temperton_nigel.html). This project involves the development and application of new cell-based assays for the study of heterosubtypic immunity to influenza and other emerging respiratory viruses (MERS/SARS coronavirus) using retroviral vector technology. The VPU is a purpose built, dedicated viral pseudotype R&D laboratory. The role of the VPU is to act as an interface between academia, industry, animal and public health laboratories with the purpose of translating basic virus research into in vitro cell culture based assays that can be readily employed for the immunogenicity testing of new vaccines, and for the screening of antivirals and therapeutic antibodies.

Entry Requirements:

Applicants should have minimum 2:1 BSc degree in Virology, Immunology, Molecular Biology, Biological Sciences, Biomedicine or Pharmacology. An MSc and/or industrial experience is desirable although not essential.

Funding:

This project is offered on a self-funding basis. It is open to applicants with their own funding or those applying to funding sources (scholarships etc).  Details of tuition fees can be found at http://www.msp.ac.uk/studying/fees-and-finance.html. An annual bench fee is also payable on top of the tuition fee to cover specialist reagents required for the research.

For further project/application information please contact Dr Nigel Temperton via LinkedIn (https://www.linkedin.com/in/nigeltemperton) or by email at n.temperton@kent.ac.uk in the first instance.

Leave a comment